At this time, posts about NKMAX are rapidly increasing on portals and stock communities. Today, foreigners have sold a net 55,000 shares of NKMAX, and institutions have sold a net 83,000 shares, according to provisional data. NKMAX is known as a manufacturer of basic pharmaceutical substances and biological preparations.


As of 12:30 PM on the 16th, NKMAX's stock price is 19,300 KRW, up 1.05% from the previous day, with a trading volume of 1,742,598 shares, which is 135.56% of the 5-day average trading volume. On December 10th, NKMAX was an issue in the market with the headline "Domestic and international NK therapy spotlighted with 3 consecutive days of rise."


Besides NKMAX, posts from investors are also surging regarding Enex (011090), Neptune (217270), and Seoul Food (004410).



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing